Skip to content

Clinical trials

Observational Prostatic Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Observational Country / region: Norway Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20091
20101
20112
20151
20173
20181
20202
20212
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting3
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital4
Norwegian University of Science and Technology2
Sykehuset Innlandet HF2
Bayer1
Blue Earth Diagnostics1
European Organisation for Research and Treatment of Cancer - EORTC1
Ferring Pharmaceuticals1
Helse Stavanger HF1
Norwegian Institute of Public Health1
Prostate Cancer Clinical Trials Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms18
Disease1
Genital Neoplasms, Male1
Neoplasm Recurrence, Local1
Prostatic Diseases1
Rectal Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.